Copyright Reports & Markets. All rights reserved.

Global Monkeypox Virus Monoclonal Antibody Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Monkeypox Virus Monoclonal Antibody Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Purity>90%
    • 1.3.3 Purity>95%
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Monkeypox Virus Monoclonal Antibody Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Diagnostic Laboratories
    • 1.4.3 Research and Academic Laboratories
    • 1.4.4 Pharmaceutical and Biotechnology Companies
  • 1.5 Global Monkeypox Virus Monoclonal Antibody Market Size & Forecast
    • 1.5.1 Global Monkeypox Virus Monoclonal Antibody Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Monkeypox Virus Monoclonal Antibody Sales Quantity (2021-2032)
    • 1.5.3 Global Monkeypox Virus Monoclonal Antibody Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 ProteoGenix
    • 2.1.1 ProteoGenix Details
    • 2.1.2 ProteoGenix Major Business
    • 2.1.3 ProteoGenix Monkeypox Virus Monoclonal Antibody Product and Services
    • 2.1.4 ProteoGenix Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 ProteoGenix Recent Developments/Updates
  • 2.2 ACROBiosystems
    • 2.2.1 ACROBiosystems Details
    • 2.2.2 ACROBiosystems Major Business
    • 2.2.3 ACROBiosystems Monkeypox Virus Monoclonal Antibody Product and Services
    • 2.2.4 ACROBiosystems Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 ACROBiosystems Recent Developments/Updates
  • 2.3 Creative Diagnostics
    • 2.3.1 Creative Diagnostics Details
    • 2.3.2 Creative Diagnostics Major Business
    • 2.3.3 Creative Diagnostics Monkeypox Virus Monoclonal Antibody Product and Services
    • 2.3.4 Creative Diagnostics Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Creative Diagnostics Recent Developments/Updates
  • 2.4 Novus Biologicals, LLC
    • 2.4.1 Novus Biologicals, LLC Details
    • 2.4.2 Novus Biologicals, LLC Major Business
    • 2.4.3 Novus Biologicals, LLC Monkeypox Virus Monoclonal Antibody Product and Services
    • 2.4.4 Novus Biologicals, LLC Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Novus Biologicals, LLC Recent Developments/Updates
  • 2.5 Merck Group
    • 2.5.1 Merck Group Details
    • 2.5.2 Merck Group Major Business
    • 2.5.3 Merck Group Monkeypox Virus Monoclonal Antibody Product and Services
    • 2.5.4 Merck Group Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Merck Group Recent Developments/Updates
  • 2.6 Absolute Antibody
    • 2.6.1 Absolute Antibody Details
    • 2.6.2 Absolute Antibody Major Business
    • 2.6.3 Absolute Antibody Monkeypox Virus Monoclonal Antibody Product and Services
    • 2.6.4 Absolute Antibody Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Absolute Antibody Recent Developments/Updates
  • 2.7 Creative Biolabs
    • 2.7.1 Creative Biolabs Details
    • 2.7.2 Creative Biolabs Major Business
    • 2.7.3 Creative Biolabs Monkeypox Virus Monoclonal Antibody Product and Services
    • 2.7.4 Creative Biolabs Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Creative Biolabs Recent Developments/Updates
  • 2.8 Sanyoubio
    • 2.8.1 Sanyoubio Details
    • 2.8.2 Sanyoubio Major Business
    • 2.8.3 Sanyoubio Monkeypox Virus Monoclonal Antibody Product and Services
    • 2.8.4 Sanyoubio Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Sanyoubio Recent Developments/Updates
  • 2.9 Cnpair
    • 2.9.1 Cnpair Details
    • 2.9.2 Cnpair Major Business
    • 2.9.3 Cnpair Monkeypox Virus Monoclonal Antibody Product and Services
    • 2.9.4 Cnpair Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Cnpair Recent Developments/Updates
  • 2.10 Vazyme
    • 2.10.1 Vazyme Details
    • 2.10.2 Vazyme Major Business
    • 2.10.3 Vazyme Monkeypox Virus Monoclonal Antibody Product and Services
    • 2.10.4 Vazyme Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Vazyme Recent Developments/Updates
  • 2.11 Sinobiological
    • 2.11.1 Sinobiological Details
    • 2.11.2 Sinobiological Major Business
    • 2.11.3 Sinobiological Monkeypox Virus Monoclonal Antibody Product and Services
    • 2.11.4 Sinobiological Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Sinobiological Recent Developments/Updates

3 Competitive Environment: Monkeypox Virus Monoclonal Antibody by Manufacturer

  • 3.1 Global Monkeypox Virus Monoclonal Antibody Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Monkeypox Virus Monoclonal Antibody Revenue by Manufacturer (2021-2026)
  • 3.3 Global Monkeypox Virus Monoclonal Antibody Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Monkeypox Virus Monoclonal Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Monkeypox Virus Monoclonal Antibody Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Monkeypox Virus Monoclonal Antibody Manufacturer Market Share in 2025
  • 3.5 Monkeypox Virus Monoclonal Antibody Market: Overall Company Footprint Analysis
    • 3.5.1 Monkeypox Virus Monoclonal Antibody Market: Region Footprint
    • 3.5.2 Monkeypox Virus Monoclonal Antibody Market: Company Product Type Footprint
    • 3.5.3 Monkeypox Virus Monoclonal Antibody Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Monkeypox Virus Monoclonal Antibody Market Size by Region
    • 4.1.1 Global Monkeypox Virus Monoclonal Antibody Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Monkeypox Virus Monoclonal Antibody Consumption Value by Region (2021-2032)
    • 4.1.3 Global Monkeypox Virus Monoclonal Antibody Average Price by Region (2021-2032)
  • 4.2 North America Monkeypox Virus Monoclonal Antibody Consumption Value (2021-2032)
  • 4.3 Europe Monkeypox Virus Monoclonal Antibody Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Monkeypox Virus Monoclonal Antibody Consumption Value (2021-2032)
  • 4.5 South America Monkeypox Virus Monoclonal Antibody Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Monkeypox Virus Monoclonal Antibody Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2021-2032)
  • 5.2 Global Monkeypox Virus Monoclonal Antibody Consumption Value by Type (2021-2032)
  • 5.3 Global Monkeypox Virus Monoclonal Antibody Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2021-2032)
  • 6.2 Global Monkeypox Virus Monoclonal Antibody Consumption Value by Application (2021-2032)
  • 6.3 Global Monkeypox Virus Monoclonal Antibody Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2021-2032)
  • 7.2 North America Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2021-2032)
  • 7.3 North America Monkeypox Virus Monoclonal Antibody Market Size by Country
    • 7.3.1 North America Monkeypox Virus Monoclonal Antibody Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Monkeypox Virus Monoclonal Antibody Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2021-2032)
  • 8.2 Europe Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2021-2032)
  • 8.3 Europe Monkeypox Virus Monoclonal Antibody Market Size by Country
    • 8.3.1 Europe Monkeypox Virus Monoclonal Antibody Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Monkeypox Virus Monoclonal Antibody Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Monkeypox Virus Monoclonal Antibody Market Size by Region
    • 9.3.1 Asia-Pacific Monkeypox Virus Monoclonal Antibody Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Monkeypox Virus Monoclonal Antibody Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2021-2032)
  • 10.2 South America Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2021-2032)
  • 10.3 South America Monkeypox Virus Monoclonal Antibody Market Size by Country
    • 10.3.1 South America Monkeypox Virus Monoclonal Antibody Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Monkeypox Virus Monoclonal Antibody Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Monkeypox Virus Monoclonal Antibody Market Size by Country
    • 11.3.1 Middle East & Africa Monkeypox Virus Monoclonal Antibody Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Monkeypox Virus Monoclonal Antibody Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Monkeypox Virus Monoclonal Antibody Market Drivers
  • 12.2 Monkeypox Virus Monoclonal Antibody Market Restraints
  • 12.3 Monkeypox Virus Monoclonal Antibody Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Monkeypox Virus Monoclonal Antibody and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Monkeypox Virus Monoclonal Antibody
  • 13.3 Monkeypox Virus Monoclonal Antibody Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Monkeypox Virus Monoclonal Antibody Typical Distributors
  • 14.3 Monkeypox Virus Monoclonal Antibody Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Monkeypox Virus Monoclonal Antibody market size was valued at US$ 1534 million in 2025 and is forecast to a readjusted size of US$ 2784 million by 2032 with a CAGR of 9.0% during review period.
    Monkeypox virus monoclonal antibodies are highly homogeneous antibodies produced by a single B cell clone and target only a specific antigenic epitope of monkeypox virus.
    This report is a detailed and comprehensive analysis for global Monkeypox Virus Monoclonal Antibody market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Monkeypox Virus Monoclonal Antibody market size and forecasts, in consumption value ($ Million), sales quantity (L), and average selling prices (US$/L), 2021-2032
    Global Monkeypox Virus Monoclonal Antibody market size and forecasts by region and country, in consumption value ($ Million), sales quantity (L), and average selling prices (US$/L), 2021-2032
    Global Monkeypox Virus Monoclonal Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (L), and average selling prices (US$/L), 2021-2032
    Global Monkeypox Virus Monoclonal Antibody market shares of main players, shipments in revenue ($ Million), sales quantity (L), and ASP (US$/L), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Monkeypox Virus Monoclonal Antibody
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Monkeypox Virus Monoclonal Antibody market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ProteoGenix, ACROBiosystems, Creative Diagnostics, Novus Biologicals, LLC, Merck Group, Absolute Antibody, Creative Biolabs, Sanyoubio, Cnpair, Vazyme, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Monkeypox Virus Monoclonal Antibody market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Purity>90%
    Purity>95%
    Others
    Market segment by Application
    Diagnostic Laboratories
    Research and Academic Laboratories
    Pharmaceutical and Biotechnology Companies
    Major players covered
    ProteoGenix
    ACROBiosystems
    Creative Diagnostics
    Novus Biologicals, LLC
    Merck Group
    Absolute Antibody
    Creative Biolabs
    Sanyoubio
    Cnpair
    Vazyme
    Sinobiological
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Monkeypox Virus Monoclonal Antibody product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Monkeypox Virus Monoclonal Antibody, with price, sales quantity, revenue, and global market share of Monkeypox Virus Monoclonal Antibody from 2021 to 2026.
    Chapter 3, the Monkeypox Virus Monoclonal Antibody competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Monkeypox Virus Monoclonal Antibody breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Monkeypox Virus Monoclonal Antibody market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Monkeypox Virus Monoclonal Antibody.
    Chapter 14 and 15, to describe Monkeypox Virus Monoclonal Antibody sales channel, distributors, customers, research findings and conclusion.

    Buy now